FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA's Overreach on Compounded Peptides Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health FDA Peptide Reclassification 2026: What Researchers Want Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA Unbans 14 Peptides for Legal US Compounding! : r Biohackers